Most clinical guidelines recommend daily bathing in lukewarm water, followed by the application of moisturizers, in the treatment of atopic dermatitis (AD), according to an expert who presented at the 23rd Asian-Australasian Regional Conference of Dermatology (RCD 2018) held in Surabaya, Indonesia.
Managing paediatric atopic dermatitis remains a huge challenge mainly because of noncompliance to treatment, but this challenge can be addressed by prescribing nonsteroidal, noncalcineurin inhibitor agents providing epidermal repair therapy, according to an expert who spoke at the 23rd Asian Australasian Regional Conference of Dermatology (RCD 2018) held in Surabaya, Indonesia.
Chronic pruritus is a diverse and aetiologically complex skin condition and thus requires a similarly comprehensive treatment approach, according to Dr Siti Aisah who gave a lecture at the recently concluded 23rd Regional Conference of Dermatology (RCD 2018) in Surabaya, Indonesia.
Serum concentration of trace zinc appears to be correlated with premature canities, while trace ferrum and copper are not, according to a poster presented at the recently concluded 23rd Regional Conference of Dermatology (RCD 2018), in Surabaya, Indonesia.
The FDA approval and subsequent use of checkpoint blockade immunotherapy (CBI) and BRAFV600 targeted therapy almost doubled the overall survival (OS) in patients with stage 4 melanoma with brain metastases (MBM), according to a recent US-based study.
DCH Auriga recently held their first Aesthetics and Suturing Workshop under the IMPACT continuing medical education series – a scientific platform that aims to cascade the latest updates on disease management and share best clinical practices among healthcare professionals in Singapore. Two experts on aesthetics and aesthetic surgery shared their insights on suturing techniques and current approaches for scar prevention and management.
Matching targeted therapy to genetic alterations in the tumour improved response rate and long-term survival in patients with advanced cancer who underwent molecular profiling compared with patients who were unmatched to therapy, highlighting the role of molecular testing in precision medicine, the IMPACT* study shows.
Dupilumab, the fully human anti-interleukin-4 receptor α monoclonal antibody indicated for the treatment of atopic dermatitis, appeared to improve lung function, reduce exacerbations, and decrease oral corticosteroid use in individuals with moderate-to-severe asthma, according to two phase III trials presented at ATS 2018.
New drug applications approved by US FDA as of 16 - 31 May which
includes New Molecular Entities (NMEs) and new biologics. It does not
include Tentative Approvals. Supplemental approvals may have occurred
since the original approval date.
Fungal microbiome, also called the mycobiome, appears to be highly variable in patients with well-characterized fungal diseases, a recent study has shown. Moreover, severe asthmatics have the highest fungal loads, along with those receiving steroid and antifungal therapy.
The use of the investigational first-in-class attachment inhibitor fostemsavir led to improved baseline viral and CD4+ T-cell counts in patients with HIV-1 infection who had limited treatment options and were failing their current antiretroviral regimen, according to the subgroup analysis results of the BRIGHTE* study presented at AIDS 2018.